PMID: 11317637Apr 25, 2001Paper

A brief behavioral activation treatment for depression. Treatment manual

Behavior Modification
C W LejuezS D Hopko

Abstract

The brief behavioral activation treatment for depression is a simple, cost-effective method for treating depression. Based on basic behavioral theory and recent evidence that the behavioral component may be the active mechanism of change in cognitive-behavioral treatments of clinical depression, the authors designed a treatment to systematically increase exposure to positive activities, and thereby improve affect and corresponding cognitions. This article describes the rationale for the treatment and provides the treatment in manual form to be utilized by patients in therapy.

References

Dec 1, 1996·Journal of Personality Assessment·A T BeckW Ranieri
Jul 1, 1961·Journal of the Experimental Analysis of Behavior·R J HERRNSTEIN
Mar 1, 1970·Journal of the Experimental Analysis of Behavior·R J Herrnstein

❮ Previous
Next ❯

Citations

Sep 16, 2003·Clinical Psychology Review·Derek R HopkoGeorg H Eifert
Jun 17, 2010·International Psychogeriatrics·Amber L PaukertMelinda A Stanley
Jul 20, 2011·Behavioural and Cognitive Psychotherapy·Brad E Bowins
Jan 27, 2010·Journal of Consulting and Clinical Psychology·Laura MacPhersonC W Lejuez
Mar 6, 2013·International Journal of Obesity : Journal of the International Association for the Study of Obesity·S PagotoS Crawford
Nov 15, 2011·Population Health Management·Richard L Brown
Nov 4, 2011·The Journal of Nervous and Mental Disease·Colin A DeppBrent T Mausbach
Mar 23, 2012·The Australian Journal of Rural Health·Alison WallisStephen Allison
Mar 14, 2009·Behavior Modification·Lisa A UebelackerIvan W Miller
Jun 22, 2010·Behavior Modification·Andrew M BuschIvan W Miller
Apr 22, 2011·Behavior Modification·Lauren M WeinstockIvan W Miller
Jul 28, 2009·Journal of Medical Internet Research·Björn MeyerMario Weiss
Feb 1, 2011·Annual Review of Clinical Psychology·Sona DimidjianPeter M Lewinsohn
Dec 3, 2014·Journal of Behavior Therapy and Experimental Psychiatry·Fredrik FolkeLisa Ekselius
Nov 16, 2005·Brain Injury : [BI]·Marie Claude Blais, Jean-Marie Boisvert
Jun 23, 2015·Scandinavian Journal of Psychology·Jonas RamneröJonathan W Kanter
Feb 5, 2011·Behavior Therapy·Melissa SnarskiJacquelyn Marcinak
May 15, 2007·Behavior Therapy·Maria E A Armento, Derek R Hopko
Dec 17, 2014·Journal of Intellectual Disability Research : JIDR·A JahodaC Davidson
Jun 23, 2004·European Journal of Pain : EJP·Kevin E VowlesJohn T Sorrell
May 28, 2016·Journal of Psychopathology and Behavioral Assessment·Tory Eisenlohr-MoulMarcus Rodriguez
Apr 5, 2013·Depression and Anxiety·Judith A Dygdon, Kimberly A Dienes
Jul 19, 2005·Clinical Psychology Review·Richard A BrownMichael J Zvolensky
Jan 15, 2013·Psychoneuroendocrinology·Sophie A VreeburgBrenda W J H Penninx
Oct 21, 2015·Frontiers in Psychology·Heidi A WaymentRobert E Till
Jan 1, 2014·Journal of Intellectual Disability Research : JIDR·J A McGillivray, M Kershaw
Oct 5, 2015·Journal of Behavior Therapy and Experimental Psychiatry·Jackie K GollanJohn Cacioppo

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.